A leading figure in semiconductor design has acknowledged that current computational power is insufficient to model how specific DNA markers behave under the influence of cancer, but predicts that advances in technology will eventually make such complex biological simulations feasible. The statement highlights the growing intersection of artificial intelligence and medical research, where exponential improvements in processing capabilities could unlock new approaches to understanding genetic diseases. While the challenge remains formidable, the optimism suggests that future hardware innovations may bridge the gap between theoretical biology and practical computational modeling. For researchers and tech enthusiasts, this reflects broader trends in leveraging next-generation computing to tackle previously intractable scientific problems.
The head of chip designer Arm says modelling how a DNA marker is impacted by cancer cannot be done now, but computers are "going to solve it".
